Table 3.
Pre-ECMO variables associated in multivariable analysis with 90-day survival in patients with severe COVID-19-associated ARDS supported by ECMO
| Odds ratio (95% CI) | p value | ||
|---|---|---|---|
| Age, years | .. | 0·012 | |
| ≤48 | 2·89 (1·41–5·93) | .. | |
| 49–56 | 2·01 (1·01–3·99) | .. | |
| ≥57 | 1 (ref) | .. | |
| Pre-ECMO renal component of the SOFA-II score, per point increase | 0·67 (0·55–0·83) | 0·0003 | |
| Time between intubation and ECMO, per day decrease | 0·91 (0·84–0·99) | 0·022 | |
| Centre with ≥30 venovenous ECMOs in previous year | 2·98 (1·46–6·04) | 0·0026 | |
ARDS=acute respiratory distress syndrome. ECMO=extracorporeal membrane oxygenation. SOFA=Sequential Organ Failure Assessment.